← Eichor
Study identifier: NCT03836248 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Study of the Contribution of Osteopathic Treatment to Classic Medical Management in Patients With Chronic Low Back Pain

Condition: Chronic Low Back Pain  ·  Sponsor: Clinique Pasteur

PhaseNA
Planned participants199
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

The management of chronic low back pain is now part of a multi-disciplinary set of proposals with the aim of adapting for each patient orientations of both medicated and non-medicated care. Very classically, analgesic treatment of stage I or II is of use, reinforced by the occasional use of NSAIDs in the absence of contraindication. In this medical attempt of the control of the pain associates a physical care (supervised exercises, physiotherapy care), cognitive and behavioral therapy, multidisciplinary care. Osteopathic treatment is a specific manual diagnostic and therapeutic procedure. This study aims to evaluate the relevance of providing osteopathic treatment in combination with classical medical treatment in the management of patients with chronic non-specific low back pain.

This description comes directly from the study's public registry record.

Talk to the study team

Barthélémy De Truchis de Varennes, MD  ·  + 33 5 62 21 35 36  ·  bdetruchis@clinique-pasteur.com

Always discuss trial participation with your own doctor first.

Locations (1)

Clinique PasteurToulouse, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03836248